Purple Biotech Ltd. - PPBT Operating profit EBITDA
Current operating profit in cash terms demonstrates asset dynamics where the value of 0.00 serves as the baseline indicator. Purple Biotech (PPBT) develops targeted tumor medications for hospitals, aiming for the global biotech market. The firm's success depends on clinical results rather than economic cycles. Amidst fierce competition, the company is implementing combination therapy regimens to maintain its position.
Purple Biotech Ltd. - analytical breakdowns and key metrics (PPBT)
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
PPBT - Net Profit|Expected Net Profit Purple Biotech|PPBT - Price to Earnings Ratio|Future Price to Earnings Multiple purple-biotech.com|PPBT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Purple Biotech|PPBT - Operating profit EBITDA|Net earnings per share for the last four quarters Purple Biotech|PPBT - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months purple-biotech.com|PPBT - Net earnings per share growth this year|Projected earnings per share increase next year Purple Biotech
Analysis of all company metrics:Kitov Pharma
Professional capital evaluates Purple Biotech (PPBT) through the lens of outsourcing efficiency, where the absence of capital expenditures for production should convert into operating cash flow growth. By analyzing the aggregate EBITDA for the period, the investor identifies net profit before interest and taxes, which allows for the detection of true cash generation peaks and prevents the acquisition of the asset at a historical high.
Competitors of Purple Biotech (PPBT)
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|ERAS: Profit before deduction of interest, taxes, depreciation and amortization|Delcath Systems - Operating profit before deduction of amortization|Operating profit EBITDA Y-mAbs Therapeutics Inc YMAB|AURA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CADL (Candel Therapeutics)|Accuray Incorporated (ARAY) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization SLS (SELLAS Life Sciences Group)|Profit before payment of interest, taxes and amortization Actuate Therapeutics|Profit before payment of interest, taxes and amortization CTOR|Operating profit EBITDA HURA|TARA - Profit before interest, taxes and amortization|Fate Therapeutics, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization WHWK|TScan - Operating profit EBITDA|CSBR: Profit before payment of interest, taxes and amortization|XBIT: Operating profit EBITDA|CVM - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization OS Therapies Incorporated|Profit before interest, taxes and amortization radiopharmtheranostics.com RADX|Operating profit before deduction of amortization ARTV (Artiva Biotherapeutics, Inc.)|Company profit before taxes, interest and amortization ANL|Operating profit EBITDA VERU (Veru Pharma)|Tempest Therapeutics Corp (TPST) - Profit before interest, taxes and amortization|Xilio - Operating profit EBITDA|Renovaro Inc. (RENB) - Operating profit before deduction of amortization|MURA: Operating profit EBITDA|Kairos Pharma - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization OnKure Therapeutics, Inc.|CytoMed - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Curis, Inc. (CRIS)|APLM: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA THAR (Tharimmune)|Advanced Biomed Inc. - Profit before payment of interest, taxes and amortization|GNPX: Operating profit before deduction of amortization|Calidi Biotherapeutics - Company profit before taxes, interest and amortization|SBFM: Operating profit EBITDA|Operating profit before deduction of amortization Xenetic Biosciences, Inc.|SLRX (Salarius Pharmaceuticals, Inc.) - Operating profit EBITDA|Operating profit EBITDA AON|Profit before payment of interest, taxes and amortization BeOne Medicines (BGNE)|Checkpoint Therapeutics Inc - Operating profit before amortization|Operating profit EBITDA ELEV (Elevation Oncology)|ICAD - Operating profit before deduction of amortization|Ikena - Operating profit EBITDA|Profit before interest, taxes and amortization Notable Labs Ltd|viracta.com (VIRX) - Profit before payment of interest, taxes and amortization|MorphoSys Corporation - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization NAYA|AAPGV: Income before deduction of interest, taxes and amortization
